slides · global inventory
Gantt Chart
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 1,118
Current window 721-750
Pages 38
Rows per page 30
Framework
721-750 of 1,118
41
PoS stands for Probability of Success. The slide uses a timeline framework to contrast traditional drug development with Absci's approach.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
05
The slide uses a pipeline table format to show the progression of various drug candidates (SPY001-SPY230) across discovery, IND-enabling, and clinical stages.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Golden Circle1 hit
13
The slide uses a Gantt-style visualization to show the progress of various drug candidates (SPY001-SPY230).Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
14
The slide uses a Gantt-style visualization to show the status of various drug development programs.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
30
The slide uses a table-like layout to represent a drug development pipeline.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
48
The slide uses a table-based timeline structure to map specific drug candidates (SPY001-004) to expected regulatory and clinical milestones.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Action1 hit
05
The slide uses a Gantt-style visualization to show drug development stages.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
20
The chart uses a horizontal bar format to represent clinical trial phases (Preclinical to Commercial) for multiple indications under four main programs.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
23
Clinical trial design schematic showing 2:1 randomization between Efgartigimod and Placebo over 24 weeks.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
26
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
12
The slide uses a Gantt-style chart to show the progress of three different diagnostic tests across four development phases.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
Includes a capital requirement estimate at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
04
The slide uses a Gantt-style chart to represent drug development progress.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
05
The slide uses a Gantt-style chart to map product development stages against clinical phases.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style layout to track drug development progress.Dare Bioscience | Investor Presentation Deck | 26 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
03
The slide uses a Gantt-style chart to map product development stages from pre-clinical to FDA approval.Dare Bioscience | Investor Presentation Deck | 27 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
21
The slide uses a horizontal bar chart style to represent a phased timeline.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a Gantt-style timeline to show progress of various therapeutic programs.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style visualization for clinical trial stages.Equillium | Investor Presentation Deck | 39 slides · Equillium
Pitch deck Investor relations 1 hit
07
The chart uses a horizontal bar format to represent development stages.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style visualization to map drug development progress against clinical phases.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem1 hit
05
The slide uses a Gantt-style visual for the 'Pre-clinical' stage, though it is not a full timeline.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a horizontal timeline with milestones mapped to specific quarters.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · Solution1 hit
14
The slide uses a timeline-based growth framework to show the transition from ICE to BEV models.Lotus Cars | SPAC Presentation Deck | 60 slides · Lotus
Pitch deck Investment bank 1 hit
25
The slide uses a timeline framework to demonstrate competitive advantage in market entry timing.Lotus Cars | SPAC Presentation Deck | 60 slides · Lotus
Pitch deck Investment bank 1 hit
05
The slide uses a Gantt-style visualization to track drug development progress.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a timeline-style layout to represent drug development stages.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Problem1 hit
19
OKYO Pharma | Results Presentation Deck | 25 slidesOKYO Pharma | Results Presentation Deck | 25 slides · OKYO Pharma
Conference presentation Investor relations 1 hit
11
Overstock | Mergers and Acquisitions Presentation Deck | 14 slidesOverstock | Mergers and Acquisitions Presentation Deck | 14 slides · Overstock
Conference presentation Investment bank 1 hit
16
The slide uses a visual box to highlight the current phase (Phase 2).Overstock | Results Presentation Deck | 25 slides · Overstock
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit